NCT06423326 2025-07-30Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic CancerEmory UniversityPhase 2 Recruiting36 enrolled
NCT01585805 2025-03-11Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting88 enrolled